TG and thyroid cancer: Thyroid cancer is the most common endocrine malignancy, with approximately 62,000 new cases per year in the USA [1].The vast majority of thyroid cancer patients respond favorably to surgery and risk-adapted postoperative therapy with thyroid hormone suppression and radioactive iodine (RAI) therapy, with external beam radiation therapy added in select high-risk situations [2, 3].